FGFR3 p.R248C
About
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) HC (1) | FGFR3 p.R248C | Bladder Urothelial Carcinoma | Erdafitinib |